Vertex Pharma stock slips 1.55 percent pre-market before the open
Published on 09/22/2026 at 02:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharma stock closed at USD 508.34 on Nasdaq on September 18, 2026, down 1.55 percent. The move left the shares below the prior close of USD 516.34.
September 18, 2026 in numbers
Vertex Pharmaceuticals Incorporated (ISIN US92532F1003, Nasdaq: VRTX) traded between USD 505.01 and USD 518.10 in the session, and volume reached 2,434,832 shares. Reuters showed the stock at USD 508.34, while the Nasdaq Composite closed at 27,122.09 and the S&P 500 at 7,764.70 on September 21, 2026, framing the move against a broad U.S. rally on the next session boundary.
For today, ad hoc news reported that the Bank of America Global Healthcare Conference follows on September 23, 2026. The same report also said MarketBeat lists the next earnings date as November 2, 2026.
Today before the open
Today the stock trades ahead of the open with a scheduled healthcare conference on September 23, 2026 and a later earnings date on November 2, 2026. Those items keep attention on the name even after the last completed session.
Vertex Pharma stock remains tied to the broader Nasdaq backdrop, with the index ending the last completed U.S. session well above 27,000 points.
